Fungal nail infection is common, slow-moving, and rarely urgent, which makes it an awkward fit for a same-day GP appointment and a natural one for telehealth. But nails are hard to diagnose from a photograph: thickened, discoloured nails can be fungal, but they can also be psoriasis, old trauma, or something that needs a face-to-face look. A private service has to build that judgement in, not just a prescription form.
Why fungal nail infection suits telehealth, with limits
Fungal nail infection (onychomycosis) ticks the boxes that make a condition suit private telehealth: it is common, it is not an emergency, and plenty of people would rather sort it online than book a GP appointment for something they find embarrassing. It also rarely needs anything a GP would do in person beyond looking at the nail, which a clear photograph can often substitute for.
The limit is diagnostic confidence. A GP or podiatrist examining a nail directly can press on it, check the surrounding skin, and compare nails side by side. A telehealth service is working from photographs and a history, so the safest model treats the cases that look classically fungal and refers anything uncertain, in the same spirit as the triage discipline in our guide to private Pharmacy First services, rather than guessing.
Oral and topical antifungals: what you can prescribe remotely
Two treatment routes cover most cases. Topical amorolfine nail lacquer is a pharmacy medicine that can be supplied after a short consultation for mild infection affecting less of the nail, applied on a weekly schedule over a long course. Oral terbinafine is prescription-only and works faster and more reliably for infection that has spread across more of the nail or into the nail bed, but it needs a proper prescribing decision behind it, not a tick-box form.
The choice usually comes down to how much of the nail is affected, how quickly the patient wants results, and whether anything in their history rules oral treatment out. Both routes take months rather than weeks to show a visible difference, since a nail only looks better once the infected part has grown out, and that is worth setting as an expectation from the first message rather than leaving the patient to assume the treatment has failed.
Who you can treat, and who you can't
The straightforward remote case is an otherwise well adult with a nail that photographs as classically fungal (yellowing, thickening, crumbling at the edge) and nothing in their history that complicates prescribing. That is the group a telehealth service should be built around; the rest need a different route.
- Diabetes, especially with reduced circulation or nerve sensation in the feet, where nail and skin problems need closer, often podiatry-linked, management
- Known liver disease or heavy alcohol use, which changes the risk profile for oral terbinafine
- Pregnancy or breastfeeding
- Other medicines that interact with oral terbinafine's liver pathway, which a proper medicines history should catch before prescribing
- A nail that does not look typically fungal, particularly a dark streak, rapid change, or bleeding, which needs a face-to-face look rather than a remote antifungal prescription
The judgement call that matters most in this vertical isn't which antifungal to prescribe. It's recognising the nail that isn't fungal at all and needs a face-to-face look instead.
Red flags and safety-netting
Safety netting for this vertical is less about acute deterioration and more about making sure the patient knows what a fungal infection does not look like. A single dark or brown-black streak running the length of a nail, especially with any bleeding or rapid change, is the one finding that should stop a telehealth prescription and prompt a face-to-face referral, since it can occasionally signal something more serious than a fungal infection.
Before starting a longer course of oral terbinafine, many prescribers will want a baseline liver function check and, depending on the length of treatment, a follow-up one, in line with the product's prescribing information; that is a prescriber decision, not something a booking flow should skip past (prescriber discretion applies throughout). A short check-in message partway through the course, asking about taste changes, digestive upset, or anything that feels wrong, catches most of the side effects worth acting on early.
Designing the remote assessment
The intake form should capture which nails are affected, how long the problem has been present, what, if anything, has already been tried, a clear photograph in good light, and a full medicines and health history rather than a shortened version. Vague or blurry photos are the most common reason a case needs a second look.
The decision point is simple to state and easy to get wrong under pressure to convert a sale: if the history and photos are consistent with a fungal infection and nothing on the exclusion list applies, prescribe; if anything is ambiguous, say so and route the patient to a face-to-face option rather than treating on a guess. Months of the wrong treatment on a misdiagnosed nail is a worse outcome for the patient, and for the brand's reputation, than losing that one sale.
A photograph can suggest a diagnosis. It can't confirm one on its own, and a telehealth service that forgets the difference will eventually treat the wrong nail for months.
Building the service: dispensing, adherence, and pricing
Operationally this is a dispensing and communication problem more than a clinical one. The pharmacy side needs to package and label a multi-month course correctly and get it to the patient reliably, which is the same discipline covered in our piece on same-day dispensing operations. Pricing usually works better as a course price or a short subscription than a single one-off charge, since patients are committing to months of treatment, not a single transaction; our comparison of subscription and one-off pricing models covers the tradeoffs.
Adherence is the quiet risk in this vertical. Because visible improvement takes so long, patients drop off a course before it has had a chance to work, then conclude the treatment did not work at all. Scheduled check-in messages through the course, not just a fulfilment confirmation, do more for outcomes here than in almost any other minor-ailment vertical.
How PExpo supports a fungal nail infection launch
PExpo sits behind the consultation as the GPhC-registered dispensing and prescribing layer: correctly labelled multi-month courses, a prescribing team that applies the exclusion criteria consistently rather than case by case, and the packaging and logistics to keep a long-running course reliable.
For a brand or clinic weighing this vertical against others, the brands page sets out how that layer plugs into an existing consultation flow without the operator having to build a dispensing pharmacy of their own.
Fungal nail infection is not one of the seven conditions covered by the NHS Pharmacy First scheme, which is exactly why a well-run private telehealth pathway has room to compete: patients who would otherwise wait for a GP slot for something non-urgent get a faster route, provided the diagnostic judgement is built in rather than assumed away. Get the exclusion list right, price for a multi-month course rather than a single sale, and keep patients engaged through a treatment that takes months to show; see the PExpo pricing page for how the dispensing layer is costed.
Frequently asked questions
Can a UK telehealth service prescribe oral antifungals for a nail infection without an in-person examination?
Yes, a UK-registered prescriber can prescribe oral terbinafine remotely, provided the consultation gathers a clear photograph, a full medicines and health history, and confirms the presentation is consistent with a fungal infection. Anything that looks atypical, or any of the standard exclusion criteria, should be referred for a face-to-face assessment instead. As with any remote prescribing, prescriber discretion applies, and the GPhC's standards for registered pharmacies providing services at a distance apply throughout.
How is this different from what's already available through NHS Pharmacy First?
Fungal nail infection is not one of the conditions covered by the NHS Pharmacy First minor ailments scheme, so patients currently have to see a GP or pay privately for a fast route to treatment. That gap is what makes it a workable private telehealth vertical, rather than a service competing directly with something already free at the point of use.
What should a brand check before adding a fungal nail infection vertical?
Confirm the dispensing partner can correctly package and label a multi-month antifungal course, has a clear referral pathway for atypical or higher-risk nails, and prices the service around the length of the course rather than a single transaction. Adherence support through the course matters more here than in most minor-ailment verticals, since visible improvement takes months rather than weeks.
